Back to Atlas
CTransientStandard research/education caution
CMP-0254
Experimental
5-Amino-1MQ
Metabolic / Thermogenic
Metabolic rate and fat-loss positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Small molecule
- Primary mechanism
- NNMT inhibition
- Primary market use
- Weight management
Pharmacology
- Molecular weight (Da)
- Salt-dependent
- Oral bioavailability
- Unknown
- Half-life
- ~2–12 h small-molecule class estimate
- Route tags
- Route-dependent / verify
- Evidence level
- Preclinical
- Clinical status
- Experimental
- Value-for-money score
- 4 / 10
Reported protocol signal
Treatment length: 20-30 days followed by 1-2 weeks off Oral: • 50-150 mg daily with food (Jay Campbell) • 150 mg daily, 30 minutes after taking NAD+ (Tailor Made Compounding Catalog)
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Requires ongoing pathway inhibition